MedTrace Logo

Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1

NCT04371900 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4700

Last updated 2025-05-21

No results posted yet for this study

Summary

This project builds on the Michigan Contraceptive Access Research and Evaluation Study (M-CARES) to evaluate the long-term effects of mothers' access to free contraceptives and reductions in unintended pregnancies on their children's well-being.

Conditions

  • Pregnancy

Interventions

BEHAVIORAL

Mother receives voucher valued at 100% of cost of name-brand IUD (March 4, 2019-March 31, 2023)

M-CARES randomized vouchers for contraception valued up to 100% of inserting a name-brand IUD (e.g., Skyla, Paraguard, Mirena) for women with out of pocket costs at Planned Parenthood. This intervention occurred from March 4, 2019, forward.

BEHAVIORAL

Mother receives voucher valued at 50% of cost of name-brand IUD (August 26, 2018-March 3, 2019)

M-CARES randomized vouchers for contraception valued up to 50% of inserting a name-brand IUD (e.g., Skyla, Paraguard, Mirena) for women with out of pocket costs at Planned Parenthood. This intervention occurred after November 4, 2019.

Sponsors & Collaborators

  • Planned Parenthood Federation of America

    collaborator OTHER

  • National Opinion Research Center

    collaborator OTHER

  • University of Michigan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
0 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-26
Primary Completion
2049-12-31
Completion
2049-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04371900 on ClinicalTrials.gov